X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Biocon Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs BIOCON LTD - Comparison Results

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. BIOCON LTD FDC LTD./
BIOCON LTD
 
P/E (TTM) x 17.5 36.6 47.8% View Chart
P/BV x 3.6 4.9 74.9% View Chart
Dividend Yield % 1.3 1.5 85.4%  

Financials

 FDC LTD.   BIOCON LTD
EQUITY SHARE DATA
    FDC LTD.
Mar-14
BIOCON LTD
Mar-16
FDC LTD./
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs144496 28.9%   
Low Rs79397 19.9%   
Sales per share (Unadj.) Rs47.6174.3 27.3%  
Earnings per share (Unadj.) Rs7.644.8 17.0%  
Cash flow per share (Unadj.) Rs9.056.9 15.8%  
Dividends per share (Unadj.) Rs2.255.00 45.0%  
Dividend yield (eoy) %2.01.1 180.4%  
Book value per share (Unadj.) Rs47.5202.8 23.4%  
Shares outstanding (eoy) m177.83200.00 88.9%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.32.6 91.4%   
Avg P/E ratio x14.610.0 146.8%  
P/CF ratio (eoy) x12.37.8 157.5%  
Price / Book Value ratio x2.32.2 106.4%  
Dividend payout %29.611.2 265.0%   
Avg Mkt Cap Rs m19,78489,220 22.2%   
No. of employees `000NA4.4 0.0%   
Total wages/salary Rs m1,2216,363 19.2%   
Avg. sales/employee Rs ThNM7,894.5-  
Avg. wages/employee Rs ThNM1,441.2-  
Avg. net profit/employee Rs ThNM2,029.7-  
INCOME DATA
Net Sales Rs m8,45934,854 24.3%  
Other income Rs m394845 46.6%   
Total revenues Rs m8,85235,699 24.8%   
Gross profit Rs m2,0708,200 25.2%  
Depreciation Rs m2492,423 10.3%   
Interest Rs m31102 30.4%   
Profit before tax Rs m2,1846,520 33.5%   
Minority Interest Rs m0-744 0.0%   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m05,754 0.0%   
Tax Rs m6062,569 23.6%   
Profit after tax Rs m1,3538,961 15.1%  
Gross profit margin %24.523.5 104.0%  
Effective tax rate %27.739.4 70.4%   
Net profit margin %16.025.7 62.2%  
BALANCE SHEET DATA
Current assets Rs m4,35539,932 10.9%   
Current liabilities Rs m1,79216,276 11.0%   
Net working cap to sales %30.367.9 44.7%  
Current ratio x2.42.5 99.1%  
Inventory Days Days4454 83.0%  
Debtors Days Days2586 28.6%  
Net fixed assets Rs m3,02539,101 7.7%   
Share capital Rs m1791,000 17.9%   
"Free" reserves Rs m8,24338,591 21.4%   
Net worth Rs m8,45340,556 20.8%   
Long term debt Rs m1120,724 0.1%   
Total assets Rs m10,55784,816 12.4%  
Interest coverage x71.464.9 110.0%   
Debt to equity ratio x00.5 0.2%  
Sales to assets ratio x0.80.4 195.0%   
Return on assets %13.110.7 122.7%  
Return on equity %16.022.1 72.4%  
Return on capital %23.519.0 123.8%  
Exports to sales %13.330.7 43.3%   
Imports to sales %3.320.4 16.4%   
Exports (fob) Rs m1,12610,717 10.5%   
Imports (cif) Rs m2837,105 4.0%   
Fx inflow Rs m1,14611,789 9.7%   
Fx outflow Rs m3558,393 4.2%   
Net fx Rs m7913,396 23.3%   
CASH FLOW
From Operations Rs m1,4855,264 28.2%  
From Investments Rs m-620-9,540 6.5%  
From Financial Activity Rs m-75310,867 -6.9%  
Net Cashflow Rs m1136,591 1.7%  

Share Holding

Indian Promoters % 68.9 40.4 170.5%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 4.7 8.4 56.0%  
FIIs % 7.5 10.7 70.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 19.9 95.5%  
Shareholders   23,730 109,995 21.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   TTK HEALTHCARE  ALEMBIC LTD  WYETH LTD  ELDER PHARMA  SUVEN LIFE  

Compare FDC LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Weak Finish to the Week Post Vishal Sikka's Exit as CEO of Infosys(Closing)

Share markets in India witnessed selling pressure, led by slump in shares of Infosys Ltd. after Vishal Sikka resigned as chief executive officer of the country's second-largest software services exporter.

Related Views on News

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Biocon: High Other Income And Licensing Income Drive Growth (Quarterly Results Update - Detailed)

Nov 7, 2016

Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.

Biocon: Lower R&D Expenses Help Margin Expansion (Quarterly Results Update - Detailed)

Sep 19, 2016

Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Aug 18, 2017 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - SANOFI INDIA COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS